Lindbrook Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $374K | Buy |
5,159
+963
| +23% | +$69.8K | 0.03% | 270 |
|
|
2024
Q4 | $311K | Buy |
4,196
+478
| +13% | +$35.4K | 0.03% | 303 |
|
|
2024
Q3 | $245K | Sell |
3,718
-378
| -9% | -$24.9K | 0.02% | 345 |
|
|
2024
Q2 | $378K | Buy |
4,096
+168
| +4% | +$15.5K | 0.04% | 245 |
|
|
2024
Q1 | $375K | Buy |
3,928
+98
| +3% | +$9.37K | 0.04% | 247 |
|
|
2023
Q4 | $292K | Buy |
3,830
+245
| +7% | +$18.7K | 0.03% | 280 |
|
|
2023
Q3 | $248K | Sell |
3,585
-511
| -12% | -$35.4K | 0.03% | 275 |
|
|
2023
Q2 | $386K | Buy |
4,096
+49
| +1% | +$4.62K | 0.04% | 216 |
|
|
2023
Q1 | $335K | Buy |
4,047
+742
| +22% | +$61.4K | 0.04% | 225 |
|
|
2022
Q4 | $247K | Sell |
3,305
-333
| -9% | -$24.8K | 0.03% | 285 |
|
|
2022
Q3 | $301K | Sell |
3,638
-97
| -3% | -$8.03K | 0.05% | 207 |
|
|
2022
Q2 | $355K | Buy |
3,735
+2,997
| +406% | +$285K | 0.06% | 196 |
|
|
2022
Q1 | $87K | Buy |
738
+94
| +15% | +$11.1K | 0.01% | 502 |
|
|
2021
Q4 | $83K | Sell |
644
-16
| -2% | -$2.06K | 0.01% | 544 |
|
|
2021
Q3 | $75K | Sell |
660
-2
| -0.3% | -$227 | 0.02% | 333 |
|
|
2021
Q2 | $69K | Buy |
662
+53
| +9% | +$5.52K | 0.02% | 379 |
|
|
2021
Q1 | $51K | Buy |
609
+86
| +16% | +$7.2K | 0.01% | 432 |
|
|
2020
Q4 | $48K | Buy |
523
+5
| +1% | +$459 | 0.01% | 408 |
|
|
2020
Q3 | $41K | Sell |
518
-10
| -2% | -$792 | 0.01% | 406 |
|
|
2020
Q2 | $36K | Buy |
528
+66
| +14% | +$4.5K | 0.01% | 438 |
|
|
2020
Q1 | $29K | Sell |
462
-426
| -48% | -$26.7K | 0.01% | 437 |
|
|
2019
Q4 | $69K | Hold |
888
| – | – | 0.02% | 344 |
|
|
2019
Q3 | $65K | Buy |
888
+78
| +10% | +$5.71K | 0.02% | 334 |
|
|
2019
Q2 | $49K | Hold |
810
| – | – | 0.02% | 433 |
|
|
2019
Q1 | $51K | Buy |
810
+270
| +50% | +$17K | 0.02% | 394 |
|
|
2018
Q4 | $27K | Buy |
+540
| New | +$27K | 0.01% | 514 |
|